|
Bio-Rad expands ddPCR multiplex mutation screening kit portfolio for cancer research
May 2016
SHARING OPTIONS:
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. has launched five new ddPCR Mutliplex Mutation Screening Kits. The kits screen for multiple key
actionable cancer mutations and wild type in a single reaction from both formalin-fixed, paraffin-embedded (FFPE) and liquid biopsy sources. The new ddPCR
Multiplex Mutation Screening Kits detect mutations in BRAF, KRAS and NRAS genes associated with numerous cancers, including lung, colorectal, ovarian,
thyroid, melanoma, breast and pancreatic cancer.
Bio-Rad Laboratories Inc.
http://www.bio-rad.com/en-
us/product/digital-pcr-assays?tab=Kits+%26+Reagents&source_wt=MultiplexKits_surlBack |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|